• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

失访的慢性丙型肝炎患者:肝病科未转诊或失访的预测因素

Chronic hepatitis C patients lost in the system: predictive factors of non-referral or loss of follow-up in Hepatology units.

作者信息

Del Pino Bellido Pilar, Guerra Veloz María Fernanda, Cordero Ruiz Patricia, Bellido Muñoz Francisco, Vega Rodríguez Francisco, Caunedo Álvarez Ángel, Carmona Soria Isabel

机构信息

Aparato Digestivo, Hospital Universitario Virgen Macarena, España.

Aparato Digestivo, Hospital Universitario Virgen Macarena, ESPAÑA.

出版信息

Rev Esp Enferm Dig. 2021 Dec;113(12):833-839. doi: 10.17235/reed.2020.7573/2020.

DOI:10.17235/reed.2020.7573/2020
PMID:33393328
Abstract

INTRODUCTION

several barriers remain in the hepatitis C care cascade, which need to be removed in order to eliminate chronic hepatitis C. These barriers include deficiencies in screening and confirmatory diagnosis as well as difficulties in accessing treatment.

AIMS

to identify factors associated with the non-referral of patients with positive hepatitis C virus (HCV) antibodies and to identify factors associated with loss of follow-up or non-attendance of these patients to specialist consultation after referral.

METHODS

observational and retrospective single-center-study, including all positive HCV serology tests performed between January 2013 and May 2018, in the Virgen Macarena health area (Seville, Spain) before implementing the one-step diagnosis. Non-referred patients and patients who were lost to follow-up after being referred were identified.

RESULTS

a total of 54 (77.4 %) patients diagnosed in Primary Care (PC) and 54 (22.2 %) from hospital specialists were not referred (p < 0.001). Predictors for non-referral were: stay in prison/institutionalization (p = 0.04), suffering chronic obstructive pulmonary disease (COPD) (p = 0.07), a normal AST value (p = 0.034) or test requested by Primary Care physician (PCP) (p = 0.004). Patients referred from PC were more likely to be lost to follow-up than those referred from hospital specialists (p < 0.001). Predictors of follow-up loss included: opioid replacement therapy (p = 0.034), absence of high blood pressure (p = 0.039) and test requested by PCP (p = 0.049).

CONCLUSIONS

a high percentage of patients with positive HCV serology were not referred or were lost to follow-up, mainly those belonging to high risk social groups or those with associated comorbidities. Patients with average values of transaminases or those diagnosed in PC were also less frequently referred.

摘要

引言

丙型肝炎治疗流程中仍存在若干障碍,为消除慢性丙型肝炎需加以消除。这些障碍包括筛查和确诊诊断方面的不足以及获得治疗的困难。

目的

确定与丙型肝炎病毒(HCV)抗体阳性患者未被转诊相关的因素,并确定这些患者在转诊后失去随访或未前往专科会诊的相关因素。

方法

进行观察性和回顾性单中心研究,纳入2013年1月至2018年5月在西班牙塞维利亚的比贞·马卡雷纳健康区实施一步诊断之前进行的所有HCV血清学检测阳性病例。确定未被转诊的患者以及转诊后失去随访的患者。

结果

共有54例(77.4%)在初级保健机构(PC)诊断的患者和54例(22.2%)来自医院专科医生诊断的患者未被转诊(p<0.001)。未被转诊的预测因素为:入狱/机构收容(p=0.04)、患有慢性阻塞性肺疾病(COPD)(p=0.07)、AST值正常(p=0.034)或由初级保健医生(PCP)要求检测(p=0.004)。与从医院专科医生处转诊的患者相比,从PC转诊的患者更易失去随访(p<0.001)。随访丢失的预测因素包括:阿片类药物替代疗法(p=0.034)无高血压(p=0.039)以及由PCP要求检测(p=0.049)。

结论

HCV血清学检测阳性的患者中有很大比例未被转诊或失去随访,主要是那些属于高风险社会群体或伴有合并症的患者。转氨酶值正常的患者或在PC诊断的患者也较少被转诊。

相似文献

1
Chronic hepatitis C patients lost in the system: predictive factors of non-referral or loss of follow-up in Hepatology units.失访的慢性丙型肝炎患者:肝病科未转诊或失访的预测因素
Rev Esp Enferm Dig. 2021 Dec;113(12):833-839. doi: 10.17235/reed.2020.7573/2020.
2
The disposition of hepatitis C antibody-positive patients in an urban hospital.城市医院丙型肝炎抗体阳性患者的处置。
J Viral Hepat. 2009 Nov;16(11):814-21. doi: 10.1111/j.1365-2893.2009.01137.x.
3
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England.《通过治疗提高丙型肝炎认识(HepCATT)研究:改善英格兰丙型肝炎病毒感染的注射吸毒者的护理衔接》。
Addiction. 2019 Jun;114(6):1113-1122. doi: 10.1111/add.14569. Epub 2019 Mar 12.
4
Clinical pathways for patients with newly diagnosed hepatitis C - what actually happens.新诊断丙型肝炎患者的临床路径——实际发生的情况
J Viral Hepat. 2006 Apr;13(4):264-71. doi: 10.1111/j.1365-2893.2005.00698.x.
5
Primary Care Perspectives on Hepatitis C Virus Screening, Diagnosis and Linking Patients to Appropriate Care.基层医疗对丙型肝炎病毒筛查、诊断及患者与适当治疗衔接的观点
Am J Med. 2017 Feb;130(2):S1-S2. doi: 10.1016/j.amjmed.2017.01.001. Epub 2017 Jan 11.
6
[Follow-up diagnostics, referral and follow-up of hepatitis B and C patients].[乙肝和丙肝患者的随访诊断、转诊及跟踪]
Ned Tijdschr Geneeskd. 2018 Jan 24;162:D2047.
7
Association of Referral Source and Substance Use with Hepatitis C Virus Outcomes at a Southern Academic Medical Center.南方一所学术医疗中心转诊来源与物质使用情况与丙型肝炎病毒治疗结果的关联
South Med J. 2022 Jun;115(6):352-357. doi: 10.14423/SMJ.0000000000001402.
8
HCV microelimination strategies: An interventional study in diagnosed patients without access to the system.HCV 微消除策略:一项针对未获得系统治疗的确诊患者的干预性研究。
Liver Int. 2021 May;41(5):928-933. doi: 10.1111/liv.14824. Epub 2021 Mar 8.
9
Outcomes of a Hepatitis C screening program at a large urban VA medical center.某大型城市退伍军人事务部医疗中心丙型肝炎筛查项目的结果
J Clin Gastroenterol. 2008 Jan;42(1):97-106. doi: 10.1097/MCG.0b013e31802dc56f.
10
Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up.献血者中的丙型肝炎:照护流程及失访预测因素
Rev Saude Publica. 2017 Apr 27;51(0):40. doi: 10.1590/S1518-8787.2017051006468.

引用本文的文献

1
Enhancing Hepatitis C Virus Testing, Linkage to Care, and Treatment Commencement in Hospitals: A Systematic Review and Meta-analysis.加强医院丙型肝炎病毒检测、与治疗的衔接及治疗启动:一项系统评价与荟萃分析
Open Forum Infect Dis. 2025 Feb 4;12(2):ofaf056. doi: 10.1093/ofid/ofaf056. eCollection 2025 Feb.